Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Purinergic P2Y Eurofins Panlabs panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Antagonist activity at human P2Y13
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Antagonist activity at P2Y13 (unknown origin)
Assay data:2 Active, 3 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Antagonist activity at human P2Y13R expressed in HEK293 cells assessed as inhibition of 2MeSADP-induced cAMP production preincubated for 0.5 hrs followed by 2MeSADP stimulation by cAMP-glo assay
Assay data:1 Active, 1 Tested
Ca++ flux assay from US Patent US10220040: "Compounds, compositions and methods useful for cholesterol mobilization"
Assay data:1 Active, 9 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Purinergic P2Y Eurofins-Panlabs radioligand binding assay
Assay data:4 Tested
Assay data:9 Tested
PRESTO-Tango GPCRome screening (P2RY13)
P2Y CEREP ligand profiling
P2Y-purinergic receptor CEREP ligand profiling
P2Y Ligand binding assay
Human P2Y13 receptor (P2Y receptors)
Assay data:15 Active, 15 Tested
Antagonist activity against P2Y13 (unknown origin) assessed as inhibition of agonist binding up to 10 uM
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of P2Y13 at 10 uM
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on